Interim results of pharmacokinetic study: Insert shows benefit as DME treatment
November 1st 2009Interim results from the first human pharmacokinetic study of an investigational extended-release intravitreal device for the treatment of diabetic macular edema suggest that it has both significant efficacy and a favorable side effect profile.
Prospective study analysis: Contrast sensitivity loss still a challenge after PRP
November 1st 2009Practitioners seeking to minimize contrast sensitivity loss following panretinal photocoagulation in patients with diabetes may choose to consider performing PRP with a pattern scan laser system instead of a conventional argon laser.
NVI-111 trial analysis: Combination treatment found effective for CNV
November 1st 2009Combination epimacular brachytherapy and anti-vascular endothelial growth factor therapy may help achieve and maintain optimal visual acuity outcomes over the long term in patients with neovascular age-related macular degeneration.
Technology: Next-generation vitrectomy is here
November 1st 2009Results from a series of bench studies evaluating a new 25+-gauge vitrectomy proble and trocar system highlight the benefits and improved performance of this technology compared with previous instrumentation for microincision vitrectomy surgery.
Dexamethasone: Data show implant improves vision in patients with RVO
November 1st 2009New data from phase III clinical trials of dexamethasone 0.7 mg intravitreal implant reaffirm that this novel pharmacotherapeutic intervention is well-tolerated and effectively improves vision in patients with macular edema secondary to a branch or central retinal vein occlusion.
Diabetic retinopathy: Association mapping holds key to understanding mechanism of major diseases
November 1st 2009Association mapping is a new perspective on the use of genomic tools that allows study of common disorders, such as diabetic retinopathy, and tries to tease apart genes as a way of studying disease pathophysiology.
CRUISE Phase III trial results: Ranibizumab safe, effective for macular edema
November 1st 2009Safety and efficacy analyses based on 6-month data collected in CRUISE phase III trial indicate a promising role of anti-vascular endothelial growth factor therapy with intravitreal ranibizumab in treatment of edema secondary to central retinal vein occlusion.
Pen-like tonometer designed to be patient-friendly
October 15th 2009A handheld tonometer that measures IOP through the eyelid and over the sclera is proving to be helpful for ophthalmologists faced with patients who are apprehensive about seeing an instrument approaching their eyesor who have a corneal abnormality.